Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.53 |
| ▸ | PPARA | Q07869 | 1/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.49 |
| ▸ | BCHE | P06276 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.46 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.46 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.46 |
| ▸ | TSPO | P30536 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7760534 | 0.88 | L3MBTL1 (0.56) | L3MBTL1ALOX5PTGS1PTGS2PARP10 | |
| Hydrochloric Acid SCHEMBL7865895 | 0.81 | LPAR1 (0.52) | L3MBTL1ALOX5PTGS1PTGS2PARP10 | |
| SCHEMBL10502279 | 0.80 | PPARG (0.56) | L3MBTL1PPARGPPARAMAOB | |
| SCHEMBL11840883 | 0.75 | L3MBTL1 (0.57) | L3MBTL1ALOX5PTGS1PTGS2MAOB | |
| SCHEMBL7758232 | 0.75 | BCHE (0.52) | ALOX5MAOBBCHEFFAR1NR4A2 | |
| SCHEMBL11465304 | 0.75 | TSHR (0.54) | L3MBTL1PPARGPPARABCHE | |
| SCHEMBL6906964 | 0.75 | NPC1 (0.47) | — | |
| SCHEMBL8935257 | 0.74 | ALOX5 (0.52) | L3MBTL1ALOX5PTGS1PTGS2PARP10 | |
| SCHEMBL10465707 | 0.74 | ALOX5 (0.58) | L3MBTL1ALOX5PTGS1PTGS2PARP10 | |
| SCHEMBL4950622 | 0.74 | NR1H3 (0.53) | L3MBTL1ALOX5PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1077949-A2 | COMBINATIONS OF PROTEIN FARNESYLTRANSFERASE AND HMG COA REDUCTASE INHIBITORS AND THEIR USE TO TREAT CANCER | WARNER-LAMBERT COMPANY (US) | 2001-02-28 | — | — | EP | claimed |
| WO-1999058505-A2 | COMBINATIONS OF PROTEIN FARNESYLTRANSFERASE AND HMG COA REDUCTASE INHIBITORS AND THEIR USE TO TREAT CANCER | WARNER-LAMBERT COMPANY (US) | 1999-11-18 | — | — | WO | claimed |
| EP-0767800-B1 | HISTIDINE AND HOMOHISTIDINE DERIVATIVES AS INHIBITORS OF PROTEIN FARNESYLTRANSFERASE | WARNER LAMBERT CO (US) | 2001-03-28 | — | — | EP | disclosed |
| EP-0767800-A1 | HISTIDINE AND HOMOHISTIDINE DERIVATIVES AS INHIBITORS OF PROTEIN FARNESYLTRANSFERASE | WARNER-LAMBERT COMPANY (US) | 1997-04-16 | — | — | EP | disclosed |
| WO-1996000736-A1 | HISTIDINE AND HOMOHISTIDINE DERIVATIVES AS INHIBITORS OF PROTEIN FARNESYLTRANSFERASE | WARNER-LAMBERT COMPANY (US) | 1996-01-11 | — | — | WO | disclosed |